Clinical Diagnostics Technology & Disease Research News | 360Dx
Using Biomarkers in Breath, Zeteo Tech Aims to Find Respiratory Infections Sooner. The Maryland-based firm reported in a recent proof-of-concept study that It used protease biomarkers to identify patients with lower respiratory tract infections.
About Us - 360Dx
360Dx is published by GenomeWeb, an independent online news organization based in New York. Since 1997, GenomeWeb has served the global community of scientists, technology professionals, and executives who use and develop the latest advanced tools in molecular biology research and diagnostics. GenomeWeb is a family brand of Crain Communications.
Diagnostic Technologies and Applications - 360Dx
Texas Hospital CEO to Pay $5.3M to Settle Allegations of Kickbacks for Testing. Jeffrey Madison had been accused of participation in a scheme to pay kickbacks to physicians for testing referrals and billing healthcare programs for the tests. Oct 3, 2024.
UBS Initiates Coverage of Veracyte With Buy Rating | 360Dx
2 days ago · NEW YORK – Investment bank UBS on Tuesday initiated coverage of molecular diagnostics firm Veracyte with a Buy rating and a 12-month price target of $43 on the company's stock. In a note to investors, UBS analysts led by Lu Li noted that the bank envisions "durable growth" in Veracyte's core products, chiefly its Afirma thyroid nodule and ...
Breaking News - 360Dx
Oct 7, 2024 · Foundation Medicine Test Approved by FDA as CDx for Itovebi in Breast Cancer Patients. The test is approved for patients with endocrine-resistant, PIK3CA-mutated, hormone receptor-positive, HER2-negative, locally advanced or metastatic breast cancer. Oct 11, 2024.
Harvard Researchers Develop AI-Based Model for Cancer Dx, …
Sep 6, 2024 · NEW YORK – Researchers from Harvard Medical School have developed a new artificial intelligence-based model for systematically diagnosing multiple cancer types and predicting patients' prognoses from digital pathology images. Described in a paper published this week in Nature, the Clinical Histopathology Imaging Evaluation Foundation (CHIEF ...
Genomics Research & Discovery - 360Dx
Oct 1, 2024 · MARAbio Systems Closes $19M Funding Round to Support Autism Test Commercialization. The company has developed a blood-based test to assess whether women are carriers of the antibodies that cause maternal autoantibody related-autism. The company is targeting its RPPA-based testing to biopharma firms as well as for clinical trial work and to ...
Abbott Q3 Diagnostics Revenues Down 2 Percent | 360Dx
2 days ago · NEW YORK – Abbott's third quarter Diagnostics revenues declined nearly 2 percent year over year, the company said on Wednesday.. For the three months ended Sept. 30, the Abbott Park, Illinois-based firm reported overall revenues of $10.64 billion, up 5 percent from $10.14 billion a year ago and beating the consensus Wall Street estimate of $10.55 billion.
Genomics Technology, Tools & Methods | 360Dx
Oct 8, 2024 · The latest news on life science tools and technology in genetics, genomics, and molecular diagnostics from 360Dx.
360Dx Index Rises 20 Percent in 2021
Jan 4, 2022 · NEW YORK – Even as the COVID-19 pandemic began showing signs of becoming manageable in 2021 and testing demand declined compared to a year ago, the stock prices of diagnostics firms generally remained robust during the past year.